HRT FINANCIAL LP

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1475597 NEW YORK, NY

Position in MRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,669,024

+$6,453,144 QoQ

Shares Held

1,068,754

+1301.0% QoQ

Ownership

0.412%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#35

of 177 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,581,551 across 184 Biotechnology names. MRVI ranks #30 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,669,024	1,068,754	+1301.0%	Shares	Defined	2026-08-14
2026-03-31	$215,880	76,283	-79.3%	Shares	Defined	2026-05-14
2025-12-31	$1,195,710	367,911	+1011.0%	Shares	Defined	2026-02-12
2025-03-31	$73,186	33,116	-78.5%	Shares	Defined	2025-05-15
2024-12-31	$837,528	153,675	-61.4%	Shares	Defined	2025-02-14
2024-03-31	$3,450,200	397,947	+254.1%	Shares	Defined	2024-05-13
2023-12-31	$736,128	112,386	+16.6%	Shares	Defined	2024-02-09
2023-06-30	$1,197,816	96,365	+443.0%	Shares	Defined	2023-08-11
2023-03-31	$248,621	17,746	+93.4%	Shares	Defined	2023-05-12
2022-06-30	$260,690	9,176	-78.4%	Shares	Defined	2022-08-12
2022-03-31	$1,500,632	42,547	-86.1%	Shares	Defined	2022-05-16
2020-12-31	$8,566,329	305,395	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.